Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual, Albert Lecube Torelló
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: Rafael Simó Canonge
Collaborators: David Martinez Selva, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 247050
Reference: MS08/00058
Duration: 01/02/2009 - 31/01/2015

Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH)

IP: Rafael Simó Canonge
Collaborators: Manuel Hernández González, Joan Montaner Villalonga, Mercè Boada Rovira, Ramon Charco Torra, José García Arumí, Albert Pahissa Berga, Josep Sánchez de Toledo Codina, Juan Lorente Guerrero, Miquel Casas Brugué, Monica Anglada Baguena, Miguel Vilardell Tarres, Sara Marsal Barril, Joan Sahuquillo Barris, Cristina Hernández Pascual, Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH), Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH)
Funding agency: Instituto de Salud Carlos III
Funding: 781267.51
Reference: CAI08/01/0034
Duration: 01/01/2009 - 31/12/2012

CIBER: Diabetes y Enfermedades Metabólicas

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Monica Higuera Urbano
Funding agency: CIBER Diabetes y Enfermedades Metabólicas
Funding: 4200000
Reference: CB07/08/0024
Duration: 01/01/2008 - 01/01/2012

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Anna Teixido Troyano

Anna Teixido Troyano

Research technician
Maternal and Fetal Medicine
Read more
M José Cano Carmona

M José Cano Carmona

Research assistant
Donation and transplantation of organs, tissues and cells
Read more
Ariadna Masot LLima

Ariadna Masot LLima

Predoctoral researcher
Clinical Neuroimmunology
Read more
Miguel Del Campo Casanelles

Miguel Del Campo Casanelles

Head of group
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.